ANIK
Anika Therapeutics, Inc. · Healthcare · Market cap $273.5M
Insiders bought $41K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Aug 5, 2026
Insider Buying
$264K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Latest filing
Aug 5, 2026
Fischetti Gary P
Anika Therapeutics, Inc. (ANIK) has 16 SEC Form 4 filings (35 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 5, 2026.
Inside the rolling window, 3 insiders at Anika Therapeutics, Inc. reported 4 open-market purchases totaling $264K and no open-market sales. Insiders have net bought $264K over the trailing 6 months. The most recent open-market filing is a purchase of 1,000 shares by Director Fischetti Gary P, dated Aug 3, 2026, worth $21K.
- Industry:Medical - Specialties
- CEO:Stephen D. Griffin
- Employees:235
- HQ:Bedford, MA, US
- IPO:1993-05-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
Fischetti Gary PFirst filing | Director | Purchase | 1,000 | $21K | Aug 5 | +6.5% | SEC ↗ |
Fischetti Gary PFirst filing | Director | Purchase | 1,000 | $20K | Aug 5 | +6.5% | SEC ↗ |
HENNEMAN JOHN B IIIFirst filing | Insider | Purchase | 5,000 | $73K | May 4 | +40.5% | SEC ↗ |
Griffin Stephen D.First filing | President and CEO | Purchase | 12,200 | $150K | Apr 30 | +64.2% | SEC ↗ |
Earnings: last 7 quarters
Congress trading ANIK 8 all-time
- DRep. Tom MalinowskiOther$1,001 - $15,0002019-10-29
- DRep. Tom MalinowskiOther$1,001 - $15,0002019-07-29
- DRep. Tom MalinowskiPurchase$1,001 - $15,0002020-02-27
- DRep. Tom MalinowskiOther$1,001 - $15,0002020-01-28
- DRep. Tom MalinowskiPurchase$1,001 - $15,0002020-02-28
- DRep. Tom MalinowskiPurchase$50,001 - $100,0002019-08-01
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ANIK have?
Anika Therapeutics, Inc. (ANIK) has 16 SEC Form 4 filings (35 transaction rows) in the rolling 365-day window, disclosed by 3 distinct insiders. Most recent filing: Aug 5, 2026.
When was the most recent SEC Form 4 filing for ANIK?
The most recent Form 4 filing for ANIK on Tracefour is dated Aug 5, 2026.
What is the net insider flow at ANIK over the last 6 months?
Over the trailing 180 days, insiders at ANIK have net bought $264K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ANIK in the current window?
Inside the rolling window, insiders at ANIK bought $264K and sold $0 based on SEC Form 4 filings.
Can I get alerts for ANIK insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Anika Therapeutics, Inc. (ANIK). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Anika Therapeutics, Inc. is in the Healthcare sector.